chr21-46161921-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001142854.2(SPATC1L):​c.691G>A​(p.Glu231Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0756 in 1,605,954 control chromosomes in the GnomAD database, including 5,497 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.061 ( 393 hom., cov: 33)
Exomes 𝑓: 0.077 ( 5104 hom. )

Consequence

SPATC1L
NM_001142854.2 missense

Scores

1
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 1.15

Publications

14 publications found
Variant links:
Genes affected
SPATC1L (HGNC:1298): (spermatogenesis and centriole associated 1 like) Enables identical protein binding activity. Predicted to act upstream of or within several processes, including actin polymerization or depolymerization; positive regulation of cAMP-dependent protein kinase activity; and positive regulation of protein kinase A signaling. Predicted to be located in sperm connecting piece. Predicted to be active in centrosome. [provided by Alliance of Genome Resources, Apr 2022]
SPATC1L Gene-Disease associations (from GenCC):
  • hearing loss disorder
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0014095306).
BP6
Variant 21-46161921-C-T is Benign according to our data. Variant chr21-46161921-C-T is described in ClinVar as Benign. ClinVar VariationId is 403469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0828 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SPATC1LNM_001142854.2 linkc.691G>A p.Glu231Lys missense_variant Exon 4 of 5 ENST00000291672.6 NP_001136326.1
SPATC1LNM_032261.5 linkc.229G>A p.Glu77Lys missense_variant Exon 3 of 4 NP_115637.3
SPATC1LXM_005261188.6 linkc.691G>A p.Glu231Lys missense_variant Exon 4 of 5 XP_005261245.1 Q9H0A9-1
SPATC1LXM_011529756.3 linkc.349G>A p.Glu117Lys missense_variant Exon 2 of 3 XP_011528058.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SPATC1LENST00000291672.6 linkc.691G>A p.Glu231Lys missense_variant Exon 4 of 5 2 NM_001142854.2 ENSP00000291672.5 Q9H0A9-1
SPATC1LENST00000330205.10 linkc.229G>A p.Glu77Lys missense_variant Exon 3 of 4 1 ENSP00000333869.6 Q9H0A9-2

Frequencies

GnomAD3 genomes
AF:
0.0610
AC:
9280
AN:
152028
Hom.:
393
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0170
Gnomad AMI
AF:
0.0768
Gnomad AMR
AF:
0.0639
Gnomad ASJ
AF:
0.0859
Gnomad EAS
AF:
0.0116
Gnomad SAS
AF:
0.0454
Gnomad FIN
AF:
0.0995
Gnomad MID
AF:
0.0506
Gnomad NFE
AF:
0.0846
Gnomad OTH
AF:
0.0651
GnomAD2 exomes
AF:
0.0648
AC:
15271
AN:
235782
AF XY:
0.0668
show subpopulations
Gnomad AFR exome
AF:
0.0148
Gnomad AMR exome
AF:
0.0356
Gnomad ASJ exome
AF:
0.0866
Gnomad EAS exome
AF:
0.0151
Gnomad FIN exome
AF:
0.0881
Gnomad NFE exome
AF:
0.0874
Gnomad OTH exome
AF:
0.0751
GnomAD4 exome
AF:
0.0772
AC:
112172
AN:
1453808
Hom.:
5104
Cov.:
35
AF XY:
0.0767
AC XY:
55522
AN XY:
723546
show subpopulations
African (AFR)
AF:
0.0143
AC:
478
AN:
33444
American (AMR)
AF:
0.0379
AC:
1693
AN:
44616
Ashkenazi Jewish (ASJ)
AF:
0.0845
AC:
2202
AN:
26052
East Asian (EAS)
AF:
0.0123
AC:
489
AN:
39660
South Asian (SAS)
AF:
0.0542
AC:
4667
AN:
86084
European-Finnish (FIN)
AF:
0.0908
AC:
4255
AN:
46884
Middle Eastern (MID)
AF:
0.0627
AC:
359
AN:
5722
European-Non Finnish (NFE)
AF:
0.0845
AC:
93870
AN:
1111154
Other (OTH)
AF:
0.0691
AC:
4159
AN:
60192
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
6456
12911
19367
25822
32278
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3344
6688
10032
13376
16720
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0610
AC:
9277
AN:
152146
Hom.:
393
Cov.:
33
AF XY:
0.0611
AC XY:
4548
AN XY:
74396
show subpopulations
African (AFR)
AF:
0.0169
AC:
703
AN:
41560
American (AMR)
AF:
0.0638
AC:
976
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.0859
AC:
298
AN:
3470
East Asian (EAS)
AF:
0.0114
AC:
59
AN:
5166
South Asian (SAS)
AF:
0.0450
AC:
217
AN:
4822
European-Finnish (FIN)
AF:
0.0995
AC:
1055
AN:
10602
Middle Eastern (MID)
AF:
0.0544
AC:
16
AN:
294
European-Non Finnish (NFE)
AF:
0.0846
AC:
5747
AN:
67912
Other (OTH)
AF:
0.0644
AC:
136
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
415
831
1246
1662
2077
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
112
224
336
448
560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0750
Hom.:
307
Bravo
AF:
0.0562
TwinsUK
AF:
0.0887
AC:
329
ALSPAC
AF:
0.0817
AC:
315
ESP6500AA
AF:
0.0160
AC:
70
ESP6500EA
AF:
0.0869
AC:
746
ExAC
AF:
0.0658
AC:
7909
Asia WGS
AF:
0.0200
AC:
69
AN:
3478
EpiCase
AF:
0.0856
EpiControl
AF:
0.0876

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jan 11, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 30177775, 28339009) -

not specified Benign:1
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.040
BayesDel_addAF
Benign
-0.67
T
BayesDel_noAF
Benign
-0.67
CADD
Benign
18
DANN
Benign
0.97
DEOGEN2
Benign
0.0028
.;T
Eigen
Benign
-0.92
Eigen_PC
Benign
-0.67
FATHMM_MKL
Benign
0.062
N
MetaRNN
Benign
0.0014
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
-1.3
.;N
PhyloP100
1.2
PrimateAI
Uncertain
0.66
T
PROVEAN
Benign
0.77
N;N
REVEL
Benign
0.023
Sift
Benign
1.0
T;T
Sift4G
Benign
0.89
T;T
Polyphen
0.0
.;B
Vest4
0.14
MPC
0.19
ClinPred
0.018
T
GERP RS
3.3
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.033
gMVP
0.43
Mutation Taster
=96/4
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs113710653; hg19: chr21-47581835; COSMIC: COSV52434259; API